Last 12 months
Inside the activity.
11 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 3 | 0 |
| Jan 2026 | 2 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 2 | 0 |
| Apr 2026 | 3 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 1 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 3, 2026 00:17 UTC |
MENZIUSO RICHARD THOMASPrincipal Accounting Officer
|
GrantRestricted Stock Units · Derivative | 36,234 | $0.00 | $0.00 |
DisclosureSEC source: 0002156820-26-000004 · form4-10022026_081031.xml · derivative · entry 2 MENZIUSO RICHARD THOMAS · CIK 0002156820 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,234 Underlying: Common Stock, par value $0.0001 · 36,234 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F3 · derivative.exercise_date: The RSUs become vested over four (4) years with 25% of the shares vesting on October 1, 2027, with the remainder vesting in equal annual installments for the following three (3) years, subject to the reporting person's continued service through the applicable vesting date, and have no expiration dat. F3 · derivative.expiration_date: The RSUs become vested over four (4) years with 25% of the shares vesting on October 1, 2027, with the remainder vesting in equal annual installments for the following three (3) years, subject to the reporting person's continued service through the applicable vesting date, and have no expiration dat. Read SEC document |
| October 01, 2026 Filed Oct 3, 2026 00:17 UTC |
MENZIUSO RICHARD THOMASPrincipal Accounting Officer
|
GrantStock Options (option to buy) · Derivative | 84,546 | $0.00 Strike: $2.76 | $0.00 |
DisclosureSEC source: 0002156820-26-000004 · form4-10022026_081031.xml · derivative · entry 1 MENZIUSO RICHARD THOMAS · CIK 0002156820 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,546 Underlying: Common Stock, par value $0.0001 · 84,546 shares Expires 2036-10-01 F1 · derivative.exercise_date: The shares underlying the option become vested and exercisable over four (4) years with 25% of the shares vesting on October 1, 2027, with the remainder vesting in equal monthly installments for the following thirty-six (36) months, subject to the reporting person's continued service on each applicable vesting date. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 20:10 UTC |
Arbet-Engels ChristopheChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001802615-26-000002 · form4-10052026_041009.xml · derivative · entry 3 Arbet-Engels Christophe · CIK 0001802615 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,500 Underlying: Common Stock, par value $0.0001 · 37,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F3 · derivative.exercise_date: The RSUs become vested over four (4) years with 25% of the shares vesting on October 1, 2026, with the remainder vesting in equal annual installments for the following three (3) years, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. F3 · derivative.expiration_date: The RSUs become vested over four (4) years with 25% of the shares vesting on October 1, 2026, with the remainder vesting in equal annual installments for the following three (3) years, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 20:10 UTC |
Arbet-Engels ChristopheChief Medical Officer
|
Tax withholdingCommon Stock, par value $0.0001 | 12,679 | $2.76 | $34,994.04 |
DisclosureSEC source: 0001802615-26-000002 · form4-10052026_041009.xml · nonDerivative · entry 2 Arbet-Engels Christophe · CIK 0001802615 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,821 F2 · kind: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 20:10 UTC |
Arbet-Engels ChristopheChief Medical Officer
|
Exercise / conversionCommon Stock, par value $0.0001 | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001802615-26-000002 · form4-10052026_041009.xml · nonDerivative · entry 1 Arbet-Engels Christophe · CIK 0001802615 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 20:05 UTC |
WEAVER GREGORY LChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 14,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001251779-26-000011 · form4-10052026_041006.xml · derivative · entry 3 WEAVER GREGORY L · CIK 0001251779 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,425 Underlying: Common Stock, par value $0.0001 · 14,475 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F3 · derivative.exercise_date: The RSUs become vested over four (4) years with 25% of the shares vesting on October 1, 2026, with the remainder vesting in equal annual installments for the following three (3) years, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. F3 · derivative.expiration_date: The RSUs become vested over four (4) years with 25% of the shares vesting on October 1, 2026, with the remainder vesting in equal annual installments for the following three (3) years, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 20:05 UTC |
WEAVER GREGORY LChief Financial Officer
|
Tax withholdingCommon Stock, par value $0.0001 | 4,379 | $2.76 | $12,086.04 |
DisclosureSEC source: 0001251779-26-000011 · form4-10052026_041006.xml · nonDerivative · entry 2 WEAVER GREGORY L · CIK 0001251779 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,927 F2 · kind: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 20:05 UTC |
WEAVER GREGORY LChief Financial Officer
|
Exercise / conversionCommon Stock, par value $0.0001 | 14,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001251779-26-000011 · form4-10052026_041006.xml · nonDerivative · entry 1 WEAVER GREGORY L · CIK 0001251779 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,306 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. Read SEC document |
| September 16, 2026 Filed Sep 17, 2026 20:05 UTC |
Richardson Linda MChief Commercial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 24,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001595064-26-000002 · form4-09172026_040911.xml · derivative · entry 3 Richardson Linda M · CIK 0001595064 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,000 Underlying: Common Stock, par value $0.0001 · 24,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F3 · derivative.exercise_date: The RSUs become vested over four (4) years with 25% of the shares vesting on September 16, 2026, with the remainder vesting in equal annual installments for the following three (3) years, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. F3 · derivative.expiration_date: The RSUs become vested over four (4) years with 25% of the shares vesting on September 16, 2026, with the remainder vesting in equal annual installments for the following three (3) years, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. Read SEC document |
| September 16, 2026 Filed Sep 17, 2026 20:05 UTC |
Richardson Linda MChief Commercial Officer
|
Tax withholdingCommon Stock, par value $0.0001 | 6,826 | $3.24 | $22,116.24 |
DisclosureSEC source: 0001595064-26-000002 · form4-09172026_040911.xml · nonDerivative · entry 2 Richardson Linda M · CIK 0001595064 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,174 F2 · kind: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs. Read SEC document |
| September 16, 2026 Filed Sep 17, 2026 20:05 UTC |
Richardson Linda MChief Commercial Officer
|
Exercise / conversionCommon Stock, par value $0.0001 | 24,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001595064-26-000002 · form4-09172026_040911.xml · nonDerivative · entry 1 Richardson Linda M · CIK 0001595064 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. Read SEC document |
| August 13, 2026 Filed Aug 13, 2026 20:05 UTC |
Durso Jerome BenedictDirector · President and CEO
|
PurchaseCommon Stock, par value $0.0001 | 15,000 | $2.95 | $44,250.00 |
DisclosureSEC source: 0001698665-26-000007 · form4-08132026_040801.xml · nonDerivative · entry 1 Durso Jerome Benedict · CIK 0001698665 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,500 Read SEC document |
| July 31, 2026 Filed Aug 3, 2026 20:05 UTC |
WEAVER GREGORY LChief Financial Officer
|
GrantCommon Stock, par value $0.0001 | 1,753 | $2.41 | $4,231.74 |
DisclosureSEC source: 0001251779-26-000009 · form4-08032026_040813.xml · nonDerivative · entry 1 WEAVER GREGORY L · CIK 0001251779 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,831 F1 · kind: These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from February 1, 2026 through July 31, 2026. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on July 31, 2026. Read SEC document |
| July 31, 2026 Filed Aug 3, 2026 20:05 UTC |
Roberts M ScotChief Scientific Officer
|
GrantCommon Stock, par value $0.0001 | 875 | $2.41 | $2,112.25 |
DisclosureSEC source: 0001705905-26-000010 · form4-08032026_040815.xml · nonDerivative · entry 1 Roberts M Scot · CIK 0001705905 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,699 F1 · kind: These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from February 1, 2026 through July 31, 2026. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on July 31, 2026. Read SEC document |
| May 01, 2026 Filed May 1, 2026 20:13 UTC |
Pisano WayneDirector
|
GrantStock Options (option to buy) · Derivative | 48,800 | $0.00 Strike: $2.82 | $0.00 |
DisclosureSEC source: 0001743611-26-000004 · form4-05012026_080524.xml · derivative · entry 1 Pisano Wayne · CIK 0001743611 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,800 Underlying: Common Stock, par value $0.0001 · 48,800 shares Expires 2036-05-01 F1 · security: The options were granted pursuant to the Company's non-employee director compensation policy. F2 · derivative.exercise_date: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following May 1, 2026, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| May 01, 2026 Filed May 1, 2026 20:08 UTC |
GILL JOHNDirector
|
GrantStock Options (option to buy) · Derivative | 48,800 | $0.00 Strike: $2.82 | $0.00 |
DisclosureSEC source: 0001409939-26-000004 · form4-05012026_080538.xml · derivative · entry 1 GILL JOHN · CIK 0001409939 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,800 Underlying: Common Stock, par value $0.0001 · 48,800 shares Expires 2036-05-01 F1 · security: The options were granted pursuant to the Company's non-employee director compensation policy. F2 · derivative.exercise_date: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following May 1, 2026, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| May 01, 2026 Filed May 1, 2026 20:23 UTC |
Lawver Teri LDirector
|
GrantStock Options (option to buy) · Derivative | 48,800 | $0.00 Strike: $2.82 | $0.00 |
DisclosureSEC source: 0001960596-26-000002 · form4-05012026_080512.xml · derivative · entry 1 Lawver Teri L · CIK 0001960596 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,800 Underlying: Common Stock, par value $0.0001 · 48,800 shares Expires 2036-05-01 F1 · security: The options were granted pursuant to the Company's non-employee director compensation policy. F2 · derivative.exercise_date: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following May 1, 2026, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| May 01, 2026 Filed May 1, 2026 20:16 UTC |
Schafer KlausDirector
|
GrantStock Options (option to buy) · Derivative | 48,800 | $0.00 Strike: $2.82 | $0.00 |
DisclosureSEC source: 0001705904-26-000002 · form4-05012026_080505.xml · derivative · entry 1 Schafer Klaus · CIK 0001705904 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,800 Underlying: Common Stock, par value $0.0001 · 48,800 shares Expires 2036-05-01 F1 · security: The options were granted pursuant to the Company's non-employee director compensation policy. F2 · derivative.exercise_date: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following May1, 2026, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| May 01, 2026 Filed May 1, 2026 20:20 UTC |
Sohn Catherine A.Director
|
GrantStock Options (option to buy) · Derivative | 48,800 | $0.00 Strike: $2.82 | $0.00 |
DisclosureSEC source: 0001555132-26-000008 · form4-05012026_080545.xml · derivative · entry 1 Sohn Catherine A. · CIK 0001555132 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,800 Underlying: Common Stock, par value $0.0001 · 48,800 shares Expires 2036-05-01 F1 · security: The options were granted pursuant to the Company's non-employee director compensation policy. F2 · derivative.exercise_date: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following May 1, 2026, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| May 01, 2026 Filed May 1, 2026 20:18 UTC |
Jorkasky DianeDirector
|
GrantStock Options (option to buy) · Derivative | 48,800 | $0.00 Strike: $2.82 | $0.00 |
DisclosureSEC source: 0001527204-26-000002 · form4-05012026_080536.xml · derivative · entry 1 Jorkasky Diane · CIK 0001527204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,800 Underlying: Common Stock, par value $0.0001 · 48,800 shares Expires 2036-05-01 F1 · security: The options were granted pursuant to the Company's non-employee director compensation policy. F2 · derivative.exercise_date: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following May 1, 2026, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| May 01, 2026 Filed May 1, 2026 20:05 UTC |
SAYARE MITCHELDirector
|
GrantStock Options (option to buy) · Derivative | 48,800 | $0.00 Strike: $2.82 | $0.00 |
DisclosureSEC source: 0001201196-26-000002 · form4-05012026_080555.xml · derivative · entry 1 SAYARE MITCHEL · CIK 0001201196 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,800 Underlying: Common Stock, par value $0.0001 · 48,800 shares Expires 2036-05-01 F1 · security: The options were granted pursuant to the Company's non-employee director compensation policy. F2 · derivative.exercise_date: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following May 1, 2026, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| May 01, 2026 Filed May 1, 2026 20:11 UTC |
Hodges PhilipDirector
|
GrantStock Options (option to buy) · Derivative | 48,800 | $0.00 Strike: $2.82 | $0.00 |
DisclosureSEC source: 0001705562-26-000002 · form4-05012026_080500.xml · derivative · entry 1 Hodges Philip · CIK 0001705562 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,800 Underlying: Common Stock, par value $0.0001 · 48,800 shares Expires 2036-05-01 F1 · security: The options were granted pursuant to the Company's non-employee director compensation policy. F2 · derivative.exercise_date: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following May 1, 2026, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| April 06, 2026 Filed Apr 6, 2026 20:05 UTC |
GILL JOHNDirector
|
PurchaseCommon Stock, par value $0.0001 | 9,200 | $3.41 | $31,349.92 |
DisclosureSEC source: 0001409939-26-000002 · form4-04062026_040403.xml · nonDerivative · entry 1 GILL JOHN · CIK 0001409939 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,700 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.4050 to $3.4080, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| April 01, 2026 Filed Apr 1, 2026 20:05 UTC |
WEAVER GREGORY LChief Financial Officer
|
PurchaseCommon Stock, par value $0.0001 | 10,000 | $3.15 | $31,499.00 |
DisclosureSEC source: 0001251779-26-000007 · form4-04012026_040406.xml · nonDerivative · entry 1 WEAVER GREGORY L · CIK 0001251779 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,078 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.1450 to $3.1499, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| April 01, 2026 Filed Apr 1, 2026 20:05 UTC |
Durso Jerome BenedictDirector · President and CEO
|
PurchaseCommon Stock, par value $0.0001 | 15,000 | $3.14 | $47,100.00 |
DisclosureSEC source: 0001698665-26-000005 · form4-04012026_040404.xml · nonDerivative · entry 1 Durso Jerome Benedict · CIK 0001698665 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,500 Read SEC document |
| March 06, 2026 Filed Mar 9, 2026 11:05 UTC |
WEAVER GREGORY LChief Financial Officer
|
PurchaseCommon Stock, par value $0.0001 | 5,000 | $3.54 | $17,700.00 |
DisclosureSEC source: 0001251779-26-000005 · form4-03092026_070301.xml · nonDerivative · entry 1 WEAVER GREGORY L · CIK 0001251779 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,078 Read SEC document |
| March 06, 2026 Filed Mar 9, 2026 11:00 UTC |
Durso Jerome BenedictDirector · President and CEO
|
PurchaseCommon Stock, par value $0.0001 | 20,000 | $3.54 | $70,790.00 |
DisclosureSEC source: 0001698665-26-000003 · form4-03092026_070301.xml · nonDerivative · entry 1 Durso Jerome Benedict · CIK 0001698665 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,500 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.5300 to $3.5500, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:10 UTC |
Roberts M ScotChief Scientific Officer
|
GrantRestricted Stock Units · Derivative | 95,430 | $0.00 | $0.00 |
DisclosureSEC source: 0001705905-26-000008 · form4-02272026_040203.xml · derivative · entry 2 Roberts M Scot · CIK 0001705905 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,430 Underlying: Common Stock, par value $0.0001 · 95,430 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F3 · derivative.exercise_date: The RSUs become vested over four (4) years with 25% of the shares vesting February 26, 2027, with the remainder vesting in equal annual installments for the following three (3) years, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. F3 · derivative.expiration_date: The RSUs become vested over four (4) years with 25% of the shares vesting February 26, 2027, with the remainder vesting in equal annual installments for the following three (3) years, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:10 UTC |
Roberts M ScotChief Scientific Officer
|
GrantStock Options (option to buy) · Derivative | 222,670 | $0.00 Strike: $4.46 | $0.00 |
DisclosureSEC source: 0001705905-26-000008 · form4-02272026_040203.xml · derivative · entry 1 Roberts M Scot · CIK 0001705905 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 222,670 Underlying: Common Stock, par value $0.0001 · 222,670 shares Expires 2036-02-26 F1 · derivative.exercise_date: The shares underlying the option become vested and exercisable over four (4) years with 25% of the shares vesting on February 26, 2027, with the remainder vesting in equal monthly installments for the following thirty-six (36) months, subject to the reporting person's continued service on each applicable vesting date. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:05 UTC |
WEAVER GREGORY LChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 111,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001251779-26-000002 · form4-02272026_040231.xml · derivative · entry 2 WEAVER GREGORY L · CIK 0001251779 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,000 Underlying: Common Stock, par value $0.0001 · 111,000 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F3 · derivative.exercise_date: The RSUs become vested over four (4) years with 25% of the shares vesting February 26, 2027, with the remainder vesting in equal annual installments for the following three (3) years, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. F3 · derivative.expiration_date: The RSUs become vested over four (4) years with 25% of the shares vesting February 26, 2027, with the remainder vesting in equal annual installments for the following three (3) years, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:05 UTC |
WEAVER GREGORY LChief Financial Officer
|
GrantStock Options (option to buy) · Derivative | 259,000 | $0.00 Strike: $4.46 | $0.00 |
DisclosureSEC source: 0001251779-26-000002 · form4-02272026_040231.xml · derivative · entry 1 WEAVER GREGORY L · CIK 0001251779 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 259,000 Underlying: Common Stock, par value $0.0001 · 259,000 shares Expires 2036-02-26 F1 · derivative.exercise_date: The shares underlying the option become vested and exercisable over four (4) years with 25% of the shares vesting on February 26, 2027, with the remainder vesting in equal monthly installments for the following thirty-six (36) months, subject to the reporting person's continued service on each applicable vesting date. Read SEC document |
| February 02, 2026 Filed Feb 3, 2026 21:15 UTC |
Roberts M ScotChief Scientific Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 7,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001705905-26-000006 · form4-02032026_040235.xml · derivative · entry 7 Roberts M Scot · CIK 0001705905 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.0001 · 7,775 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F6 · derivative.exercise_date: The RSUs become vested in substantially equal annual installments over the 4 years following February 2, 2022, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. F6 · derivative.expiration_date: The RSUs become vested in substantially equal annual installments over the 4 years following February 2, 2022, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. Read SEC document |
| February 02, 2026 Filed Feb 3, 2026 21:15 UTC |
Roberts M ScotChief Scientific Officer
|
Tax withholdingCommon Stock, par value $0.0001 | 2,329 | $5.55 | $12,925.95 |
DisclosureSEC source: 0001705905-26-000006 · form4-02032026_040235.xml · nonDerivative · entry 5 Roberts M Scot · CIK 0001705905 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,824 F2 · kind: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs. Read SEC document |
| February 02, 2026 Filed Feb 3, 2026 21:15 UTC |
Roberts M ScotChief Scientific Officer
|
Exercise / conversionCommon Stock, par value $0.0001 | 7,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001705905-26-000006 · form4-02032026_040235.xml · nonDerivative · entry 4 Roberts M Scot · CIK 0001705905 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,153 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. Read SEC document |
| January 31, 2026 Filed Feb 2, 2026 21:15 UTC |
Garg Vipin KDirector
|
GrantCommon Stock, par value $0.0001 | 6,926 | $3.07 | $21,262.82 |
DisclosureSEC source: 0001515813-26-000006 · form4-02022026_040201.xml · nonDerivative · entry 3 Garg Vipin K · CIK 0001515813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 424,519 F3 · kind: These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from August 1, 2025 through January 31, 2026 F4 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on August 1, 2025 Read SEC document |
| January 31, 2026 Filed Feb 2, 2026 21:10 UTC |
Jordt Raymond MChief Business Officer
|
GrantCommon Stock, par value $0.0001 | 4,571 | $3.07 | $14,032.97 |
DisclosureSEC source: 0001960780-26-000008 · form4-02022026_040201.xml · nonDerivative · entry 1 Jordt Raymond M · CIK 0001960780 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,107 F1 · kind: These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from August 1, 2025 through January 31, 2026. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on August 1, 2025. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 21:15 UTC |
Roberts M ScotChief Scientific Officer
|
GrantCommon Stock, par value $0.0001 | 5,567 | $3.07 | $17,090.69 |
DisclosureSEC source: 0001705905-26-000006 · form4-02032026_040235.xml · nonDerivative · entry 3 Roberts M Scot · CIK 0001705905 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,378 F3 · kind: These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from August 1, 2025 through January 31, 2026. F4 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on August 1, 2025. Read SEC document |
| January 30, 2026 Filed Feb 2, 2026 21:15 UTC |
Garg Vipin KDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 26,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001515813-26-000006 · form4-02022026_040201.xml · derivative · entry 4 Garg Vipin K · CIK 0001515813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,775 Underlying: Common Stock, par value $0.0001 · 26,775 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F5 · derivative.exercise_date: The RSUs become vested in substantially equal annual installments over the 4 years following January 30, 2023, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. F5 · derivative.expiration_date: The RSUs become vested in substantially equal annual installments over the 4 years following January 30, 2023, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. Read SEC document |
| January 30, 2026 Filed Feb 2, 2026 21:15 UTC |
Garg Vipin KDirector
|
Tax withholdingCommon Stock, par value $0.0001 | 11,632 | $5.60 | $65,139.20 |
DisclosureSEC source: 0001515813-26-000006 · form4-02022026_040201.xml · nonDerivative · entry 2 Garg Vipin K · CIK 0001515813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 417,593 F2 · kind: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs. Read SEC document |
| January 30, 2026 Filed Feb 2, 2026 21:15 UTC |
Garg Vipin KDirector
|
Exercise / conversionCommon Stock, par value $0.0001 | 26,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001515813-26-000006 · form4-02022026_040201.xml · nonDerivative · entry 1 Garg Vipin K · CIK 0001515813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 429,225 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 21:15 UTC |
Roberts M ScotChief Scientific Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 9,275 | $0.00 | $0.00 |
DisclosureSEC source: 0001705905-26-000006 · form4-02032026_040235.xml · derivative · entry 6 Roberts M Scot · CIK 0001705905 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,275 Underlying: Common Stock, par value $0.0001 · 9,275 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F5 · derivative.exercise_date: The RSUs become vested in substantially equal annual installments over the 4 years following January 30, 2023, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. F5 · derivative.expiration_date: The RSUs become vested in substantially equal annual installments over the 4 years following January 30, 2023, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 21:15 UTC |
Roberts M ScotChief Scientific Officer
|
Tax withholdingCommon Stock, par value $0.0001 | 2,859 | $5.60 | $16,010.40 |
DisclosureSEC source: 0001705905-26-000006 · form4-02032026_040235.xml · nonDerivative · entry 2 Roberts M Scot · CIK 0001705905 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,811 F2 · kind: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 21:15 UTC |
Roberts M ScotChief Scientific Officer
|
Exercise / conversionCommon Stock, par value $0.0001 | 9,275 | $0.00 | $0.00 |
DisclosureSEC source: 0001705905-26-000006 · form4-02032026_040235.xml · nonDerivative · entry 1 Roberts M Scot · CIK 0001705905 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,670 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 21:15 UTC |
Jordt Raymond MChief Business Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 15,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001960780-26-000006 · form4-01292026_040101.xml · derivative · entry 3 Jordt Raymond M · CIK 0001960780 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,550 Underlying: Common Stock, par value $0.0001 · 15,850 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F3 · derivative.exercise_date: The RSUs vest in substantially equal annual installments over the 4 years following January 27, 2025, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. F3 · derivative.expiration_date: The RSUs vest in substantially equal annual installments over the 4 years following January 27, 2025, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 21:15 UTC |
Jordt Raymond MChief Business Officer
|
Tax withholdingCommon Stock, par value $0.0001 | 4,229 | $6.18 | $26,135.22 |
DisclosureSEC source: 0001960780-26-000006 · form4-01292026_040101.xml · nonDerivative · entry 2 Jordt Raymond M · CIK 0001960780 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,536 F2 · kind: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 21:15 UTC |
Jordt Raymond MChief Business Officer
|
Exercise / conversionCommon Stock, par value $0.0001 | 15,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001960780-26-000006 · form4-01292026_040101.xml · nonDerivative · entry 1 Jordt Raymond M · CIK 0001960780 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 21:10 UTC |
Garg Vipin KDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 41,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001515813-26-000004 · form4-01292026_040103.xml · derivative · entry 3 Garg Vipin K · CIK 0001515813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,600 Underlying: Common Stock, par value $0.0001 · 41,200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F3 · derivative.exercise_date: The RSUs vest in substantially equal annual installments over the 4 years following January 27, 2025, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. F3 · derivative.expiration_date: The RSUs vest in substantially equal annual installments over the 4 years following January 27, 2025, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 21:10 UTC |
Garg Vipin KDirector
|
Tax withholdingCommon Stock, par value $0.0001 | 17,898 | $6.18 | $110,609.64 |
DisclosureSEC source: 0001515813-26-000004 · form4-01292026_040103.xml · nonDerivative · entry 2 Garg Vipin K · CIK 0001515813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 402,450 F2 · kind: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 21:10 UTC |
Garg Vipin KDirector
|
Exercise / conversionCommon Stock, par value $0.0001 | 41,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001515813-26-000004 · form4-01292026_040103.xml · nonDerivative · entry 1 Garg Vipin K · CIK 0001515813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 420,348 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 21:05 UTC |
Roberts M ScotChief Scientific Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 15,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001705905-26-000004 · form4-01292026_040101.xml · derivative · entry 3 Roberts M Scot · CIK 0001705905 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,550 Underlying: Common Stock, par value $0.0001 · 15,850 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F3 · derivative.exercise_date: The RSUs vest in substantially equal annual installments over the 4 years following January 27, 2025, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. F3 · derivative.expiration_date: The RSUs vest in substantially equal annual installments over the 4 years following January 27, 2025, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.